Hinge Health stock had its Relative Strength (RS) Rating upgraded from 84 to 91 Monday.
Here Are 3 Keys For Successful Stock Investing
This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks compares to all the other stocks in our database.
Over 100 years of market history shows that the stocks that go on to make the biggest gains tend to have an RS Rating of above 80 in the early stages of their moves.
The stock, which is on theIPO Leaders list is now considered extended and out of buy range after clearing a 43.80 buy point in a first-stage ipo base. See if the Hinge Health stock forms a new pattern or follow-on buying opportunity like a three-weeks tight or pullback to the 50-day or 10-week line.
The health care software company reported 0% earnings growth last quarter. Sales increased 50%. The next quarterly results are expected on or around Aug. 5.
Hinge Health stock holds the No. 4 rank among its peers in the Medical-Products industry group. Boston Scientific is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
